Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.12 | -$0.11 | -$0.12 |
| Q2 2026 | 1 | -$0.11 | -$0.10 | -$0.11 |
| Q3 2026 | 1 | -$0.15 | -$0.14 | -$0.15 |
| Q4 2026 | 1 | $0.41 | $0.43 | $0.42 |
| Q1 2027 | 1 | -$0.05 | -$0.05 | -$0.05 |
| Q2 2027 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2027 | 1 | -$0.04 | -$0.04 | -$0.04 |
| Q4 2027 | 1 | $0.46 | $0.48 | $0.47 |
Biofrontera Inc last posted its earnings results on Thursday, May 14th, 2026. The company reported $-0.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.18 by $0.23. The company had revenue of 10.08 M for the quarter and had revenue of 41.71 M for the year. Biofrontera Inc has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -0.87. Biofrontera Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q1 2026 | -$0.18 | -$0.41 | -0.23 | $10.25 M | $10.08 M |
| 03/19/2026 | Q4 2025 | $0.29 | $0.48 | 0.19 | $16.15 M | $17.10 M |
| 11/12/2025 | Q3 2025 | -$0.60 | -$0.62 | -0.02 | $7.00 M | $6.99 M |
| 08/13/2025 | Q2 2025 | -$0.45 | -$0.57 | -0.12 | $8.30 M | $9.03 M |
| 05/15/2025 | Q1 2025 | -$0.14 | -$0.76 | -0.62 | $10.55 M | $8.59 M |
| 03/20/2025 | Q4 2024 | N/A | -$0.19 | N/A | $14.55 M | $12.56 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.98 | N/A | $10.00 M | $9.01 M |
| 08/14/2024 | Q2 2024 | -$1.19 | -$0.05 | 1.14 | $8.21 M | $7.84 M |
| 05/15/2024 | Q1 2024 | -$1.63 | -$2.88 | -1.25 | $10.86 M | $7.90 M |
| 03/15/2024 | Q4 2023 | -$1.19 | $1.65 | 2.84 | N/A | $10.60 M |
| 11/09/2023 | Q3 2023 | -$4.23 | -$4.64 | -0.41 | N/A | $8.90 M |
| 08/11/2023 | Q2 2023 | -$5.14 | -$7.23 | -2.09 | N/A | $5.85 M |
| 05/12/2023 | Q1 2023 | -$4.40 | -$5.60 | -1.2 | N/A | $8.73 M |
| 03/13/2023 | Q4 2022 | N/A | -$2.09 | N/A | N/A | $10.14 M |
| 11/14/2022 | Q3 2022 | -$6.40 | -$2.26 | 4.14 | N/A | $4.32 M |
| 08/12/2022 | Q2 2022 | -$6.20 | $7.51 | 13.71 | N/A | $4.46 M |
| 05/13/2022 | Q1 2022 | -$2.80 | $6.50 | 9.3 | N/A | $9.75 M |
| 04/08/2022 | Q4 2021 | N/A | -$25.90 | N/A | N/A | $9.17 M |
| 11/30/2021 | Q3 2021 | -$11.60 | -$40.03 | -28.43 | N/A | $4.33 M |
| 06/30/2021 | Q2 2021 | N/A | -$9.20 | N/A | N/A | $5.86 M |
The conference call for Biofrontera Inc's latest earnings report can be listened to online.
The conference call transcript for Biofrontera Inc's latest earnings report can be read online.
Biofrontera Inc (:BFRI) has a recorded annual revenue of $41.71 M.
Biofrontera Inc (:BFRI) has a recorded net income of $-10,536,000.Biofrontera Inc has generated $-1.04 earnings per share over the last four quarters.
Biofrontera Inc (:BFRI) has a price-to-earnings ratio of -0.87 and price/earnings-to-growth ratio is -0.02.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED